In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pfizer brand of cabergoline Drug Master File in Korea (Pfizer brand of cabergoline KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pfizer brand of cabergoline. The MFDS reviews the Pfizer brand of cabergoline KDMF as part of the drug registration process and uses the information provided in the Pfizer brand of cabergoline KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pfizer brand of cabergoline KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pfizer brand of cabergoline API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pfizer brand of cabergoline suppliers with KDMF on PharmaCompass.